Cite
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase.
MLA
Beck, G., et al. “(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-Phenyl-3-Butenyl]-2’-Isobutyl-2’-(Methanesulfonyl)-4-Methylvalerohydrazide (Ro 32-7315), a Selective and Orally Active Inhibitor of Tumor Necrosis Factor-Alpha Convertase.” The Journal of Pharmacology and Experimental Therapeutics, vol. 302, no. 1, July 2002, pp. 390–96. EBSCOhost, https://doi.org/10.1124/jpet.302.1.390.
APA
Beck, G., Bottomley, G., Bradshaw, D., Brewster, M., Broadhurst, M., Devos, R., Hill, C., Johnson, W., Kim, H.-J., Kirtland, S., Kneer, J., Lad, N., Mackenzie, R., Martin, R., Nixon, J., Price, G., Rodwell, A., Rose, F., Tang, J.-P., … Worth, E. (2002). (E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2’-isobutyl-2’-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase. The Journal of Pharmacology and Experimental Therapeutics, 302(1), 390–396. https://doi.org/10.1124/jpet.302.1.390
Chicago
Beck, G, G Bottomley, D Bradshaw, M Brewster, M Broadhurst, R Devos, C Hill, et al. 2002. “(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-Phenyl-3-Butenyl]-2’-Isobutyl-2’-(Methanesulfonyl)-4-Methylvalerohydrazide (Ro 32-7315), a Selective and Orally Active Inhibitor of Tumor Necrosis Factor-Alpha Convertase.” The Journal of Pharmacology and Experimental Therapeutics 302 (1): 390–96. doi:10.1124/jpet.302.1.390.